Advanced Research in Proteinopathies

Dear Colleagues,

Proteinopathies are a family of diseases characterized by the accumulation of specific proteins within neurons or in the brain parenchyma that lead to synaptic dysfunction and neuronal loss. Examples for proteinopathies are Alzheimer’s disease, Parkinson’s disease, Lewy body disease, amyotrophic lateral sclerosis and fronto-temporal lobar degeneration. Typically, in a disease condition, the unstructured proteins change their conformation leading to small oligomers that eventually aggregate into higher-order structures. Prion disease is an exception within the family of proteinopathies, as the aggregated prion protein is highly infectious and can self-aggregate and propagate.

Over the years, the structural and morphological features of several protein aggregate species have been investigated, as well as the cellular events that lead to neuronal dysfunction. Moreover, a number of potential therapeutic strategies have been explored, including small molecules, antibodies and natural compounds, some of them showing promising outcomes.

This Special Issue welcomes the submission of original research papers and reviews on the most advanced developments in the above-mentioned topics, with special attention on possible therapeutic approaches targeting misfolded proteins.

Dr. Claudia Capitini
Dr. Manuela Leri
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• protein misfolding
• oligomers
• amyloid fibrils
• amorphous aggregates
• prion
• neurodegeneration
• aggregation kinetics
• neurotoxicity
• drug discovery